We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current CLVSF market cap is 482.76M. The company's latest EPS is SEK 4.9613 and P/E is 4.08.
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
Total Revenue | 364.81M | 461.77M | 471.44M | 565.55M | 639.34M |
Operating Income | 111.61M | 126.58M | 110.27M | 162.73M | 158.27M |
Net Income | 88.69M | 99.17M | 89.48M | 125.34M | 118.34M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
Total Assets | 372.78M | 641.71M | 668.03M | 825.21M | 891.75M |
Total Liabilities | 82.41M | 293.34M | 238.41M | 281.93M | 250.12M |
Total Equity | 290.38M | 348.37M | 429.62M | 543.28M | 641.63M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | SEK (SEK) | |
Operating | 74.07M | 125.99M | 71.12M | 159.72M | 137.29M |
Investing | -23.86M | -266.3M | -34.96M | -84.34M | -70.01M |
Financing | -35.78M | 72.98M | -35.22M | -48.48M | -90.41M |
Market Cap | 482.76M |
Price to Earnings Ratio | 4.08 |
Price to Sales Ratio | 0.76 |
Price to Cash Ratio | 4.47 |
Price to Book Ratio | 0.75 |
Dividend Yield | - |
Shares Outstanding | 23.85M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 500 |
52 Week Change | 21.05% |
52 Week High | 23.75 |
52 Week Low | 16.72 |
Spread (Intraday) | 0.95 (4.23%) |
Company Name | Cellavision AB Foreign (PK) |
Address |
ideon science park lund SE 223 70 |
Website | https://www.cellavision.com |
Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions